BiopharmaTrend.com

Cytox

Cytox

Private company
CYTOX

Cytox Group Limited provides non-invasive, risk assessment and patient stratification tools for Alzheimer's disease and dementia. Cytox’s mission is to transform how new treatments are developed, people are screened, and how patients are managed within the Alzheimer’s disease care pathway..


Founded
2004
Status
Private company
Geography
United Kingdom based
Funding
$15.573 M
Patents
1
Research papers
2

Products

genoSCORE

genoSCORE™ combines Cytox’s proprietary technologies variaTECT™, a single nucleotide polymorphism (SNP) profiling array, with SNPfitR™analytical and interpretive software, to give …

Read more

genoTOR

genoTOR™ characterises an individual’s genetic profile linked to mTOR-regulated signalling pathways, mechanisms known to affect the risk of Alzheimer's and …

Read more

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page